Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Zarir F UdwadiaMonika Tandon

Abstract

To assess the efficacy and safety of favipiravir in adults with mild-to-moderate coronavirus disease 2019 (COVID-19). In this randomized, open-label, parallel-arm, multicenter, phase 3 trial, adults (18-75 years) with RT-PCR confirmed COVID-19 and mild-to-moderate symptoms (including asymptomatic) were randomized 1:1 to oral favipiravir (day 1: 1800 mg BID and days 2-14: 800 mg BID) plus standard supportive care versus supportive care alone. The primary endpoint was time to the cessation of viral shedding; time to clinical cure was also measured. From May 14 to July 3, 2020, 150 patients were randomized to favipiravir (n = 75) or control (n = 75). Median time to the cessation of viral shedding was 5 days (95% CI: 4 days, 7 days) versus 7 days (95% CI: 5 days, 8 days), P = 0.129, and median time to clinical cure was 3 days (95% CI: 3 days, 4 days) versus 5 days (95% CI: 4 days, 6 days), P = 0.030, for favipiravir and control, respectively. Adverse events were observed in 36% of favipiravir and 8% of control patients. One control patient died due to worsening disease. The lack of statistical significance on the primary endpoint was confounded by limitations of the RT-PCR assay. Significant improvement in time to clinical cure sug...Continue Reading

References

Oct 3, 2013·Antiviral Research·Yousuke FurutaDale L Barnard
Jun 2, 2016·Health Technology Assessment : HTA·Carl J HeneghanTom Jefferson
Aug 5, 2017·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Yousuke FurutaTakaaki Nakamura
Mar 11, 2018·Antiviral Research·Leen DelangJohan Neyts
Mar 10, 2020·Drug Discoveries & Therapeutics·Liying DongJianjun Gao
Apr 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kaijin XuLanjuan Li
May 7, 2020·Journal of Translational Medicine·Luigi BuonaguroFranco M Buonaguro
May 14, 2020·The European Respiratory Journal·Yu FuWei Yan
May 20, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Lin QiZhihong Li
Jun 1, 2020·Infection, Disease & Health·Arabella WiddersJennifer Broom
Jun 3, 2020·Journal of Medical Virology·Anália CarmoFernando Rodrigues
Jul 8, 2020·International Journal of Antimicrobial Agents·Yang SongYun Lu
Jul 15, 2020·Open Forum Infectious Diseases·Joshua T SchifferLawrence Corey
Aug 22, 2020·JAMA : the Journal of the American Medical Association·Christoph D SpinnerUNKNOWN GS-US-540-5774 Investigators
Sep 9, 2020·Medical Journal, Armed Forces India·Umang AgrawalZarir F Udwadia

❮ Previous
Next ❯

Citations

Jan 17, 2021·Journal of Clinical Medicine·Ryta ŁagockaAndrzej Pawlik
Aug 1, 2020·BMJ : British Medical Journal·Reed Ac SiemieniukRomina Brignardello-Petersen
Feb 19, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Mahender Kumar MedisettySanjay Pujari
Apr 1, 2021·Photodiagnosis and Photodynamic Therapy·Leyla HazarUğur Keklikçi
Apr 28, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Satoshi FujiiSatoshi Takahashi
May 9, 2021·Expert Review of Respiratory Medicine·Matteo BassettiDaniele Roberto Giacobbe
May 22, 2021·Klinische Monatsblätter für Augenheilkunde·Maren BormannAdalbert Krawczyk
Jun 1, 2021·Frontiers in Molecular Biosciences·Miao Mei, Xu Tan
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Aliye Gediz ErturkTuba Yildirim
Jul 3, 2021·Life·Justyna Olszewska-ParasiewiczDariusz A Kosior
Jun 16, 2021·Current Opinion in Virology·Robert M Cox, Richard K Plemper
Jun 29, 2021·Acute Medicine & Surgery·Kazuma YamakawaUNKNOWN Special Committee of the Japanese Clinical Practice Guidelines for the Management of Sepsis, Septic Shock 2020 (J‐SSCG 2020)
Jul 14, 2021·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chih-Cheng LaiPo-Ren Hsueh
Jul 29, 2021·Clinical Microbiology Reviews·Kaiming TaoRobert W Shafer
Jun 19, 2021·Toxicological Sciences : an Official Journal of the Society of Toxicology·Shota YanagidaYasunari Kanda
Aug 1, 2021·Inflammopharmacology·Ammara SaleemMohamed M Abdel-Daim
Aug 3, 2021·Journal of Clinical Pharmacy and Therapeutics·Masao SekimotoNorikazu Kikuchi
Aug 5, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Batu ÖzlüşenÖnder Ergönül
Aug 13, 2021·Physical Chemistry Chemical Physics : PCCP·Barbora SedmidubskáJaroslav Kočišek
Aug 25, 2021·Computational and Structural Biotechnology Journal·Zhonglei WangXian-En Zhao
Aug 29, 2021·Pharmaceuticals·Victoria Gil MartínezSonia Santander Ballestín
Aug 27, 2021·Drug Discoveries & Therapeutics·Rohit KumarNitin Gupta
Aug 29, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Andrea SpiniLuigia Trabace
Sep 1, 2021·Journal of Infection and Public Health·Zainab AlmoosaAbbas Al Mutair
Oct 16, 2021·Frontiers in Public Health·Chenyang ZhangGuosheng Yin
Nov 17, 2021·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Faiha M Al-ArdhiNaser F Al-Tannak

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
pregnancy test

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved